Tirzepatide is contraindicated for individuals with a personal or family history of thyroid cancer or multiple endocrine neoplasia syndrome type 2 (MEN2)
Identity: PubChem CID 9831659 lists Ipamorelin as C38H49N9O5 with molecular weight 711.9 g/mol
6.9 Treatment of gPRLomas DAs (primarily CAB) are proven to be an effective and well-tolerated first line of therapy in men with gPRLomas
As with other drugs, some of the effects are desirable, and some are not
If not, here is the ingredients: ricinus communis (castor) seed oil, butyrospermum parkii (shea butter), helianthus annuus (sunflower) seed oil, hydrogenated polyisobutene, glycerin, bis-diglyceryl polyacyladipate-2, copernicia cerifera cera/copernicia cerifera (carnauba) wax/cire de carnauba, olea europaea (olive) fruit oil, aroma/flavor, cera alba/beeswax/cire dabeille, candelilla cera/euphorbia cerifera (candelilla) wax/cire de candelilla, c18-38 alkyl hydroxystearoyl stearate, hydrogenated castor oil, octyldodecanol, c12-16 alcohols, irvingia gabonensis kernel butter, dipalmitoyl hydroxyproline, hydrogenated coco-glycerides, tocopheryl acetate, beta vulgaris/beta vulgaris (beet) root extract/extrait de racine de betterave, melia azadirachta leaf extract, palmitic acid, retinyl palmitate, eclipta prostrata extract, moringa pterygosperma seed oil, hydrogenated lecithin, tocopherol, aqua/water/eau, benzyl benzoate, limonene, phenoxyethanol
